Careers  |  Sign In  |  Register  |   Twitter

Latest in Business of Medicine

While pharmaceutical companies have developed many strategies for preventing their drugs from entering the market place as generics, The New York Times reports that federal regulators say the latest tactics are illegal. “Brand-name drug makers are refusing to sell their products to generic companies, which...
The debate over whether human genes can be patented continues, as the Supreme Court will hear the case of Myriad Genetics this week. An article in The New York Times explains the company holds patents for “two human genes, which, when mutated, give a woman a high risk of getting breast or ovarian cancer....
While a decade ago tele-ICUs were regarded as the new standard of critical care, an article in The New York Times reports that “Today, with the growth of such systems stalled at about 10 percent of ICU patients nationwide, and wildly contradictory studies about the results, no one can say with authority...